Southwood Jessica E, Hoekzema Craig R, Samuels Tina L, Wells Clive, Poetker David M, Johnston Nikki, Loehrl Todd A
Division of Rhinology and Sinus Surgery, Department of Otolaryngology & Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Division of Rhinology and Sinus Surgery, Department of Otolaryngology & Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
Ann Otol Rhinol Laryngol. 2015 Dec;124(12):957-64. doi: 10.1177/0003489415593556. Epub 2015 Jun 30.
To describe potential mechanisms by which pepsin induces inflammation in refractive chronic rhinosinusitis (CRS). Our hypothesis was that pepsin induces mitochondrial damage and cytokine expression in human nasal epithelial cells (HNEpC) in vitro.
Western blot was used to detect pepsin in sinus lavages from patients with CRS and controls. The HNEpC cells were treated with pepsin (pH 7; 0.1 mg/mL) for 1 or 16 hours and routine electron microscopy (EM) and MTT assay were performed. Cytokine ELISA was performed on media collected from HNEpC cells 16 hours following a 1-hour pepsin treatment.
Pepsin was detected in sinus lavages from 4 out of 6 CRS patients and 0 out of 3 controls. The EM showed mitochondrial damage in pepsin-treated HNEpC cells but not in control cells. The MTT assay demonstrated reduced mitochondrial activity in pepsin-treated HNEpC cells compared to controls (P < .001). Pepsin increased IL-1A (P = .003) and IL-6 (P = .04) expression in HNEpC cells.
Pepsin in sinus lavages from patients with CRS is consistent with previous studies. This study reveals the damaging effect of pepsin on mitochondria in nasal epithelial cells in vitro. Cytokines previously associated with CRS were elevated following pepsin treatment of HNEpC cells in vitro. These results demonstrate mechanisms by which pepsin may potentiate CRS.
描述胃蛋白酶在难治性慢性鼻-鼻窦炎(CRS)中诱发炎症的潜在机制。我们的假设是胃蛋白酶在体外可诱导人鼻上皮细胞(HNEpC)发生线粒体损伤并促进细胞因子表达。
采用蛋白质免疫印迹法检测CRS患者和对照组鼻窦灌洗液中的胃蛋白酶。将HNEpC细胞用胃蛋白酶(pH 7;0.1 mg/mL)处理1或16小时,然后进行常规电子显微镜(EM)检查和MTT检测。在胃蛋白酶处理1小时后16小时,对从HNEpC细胞收集的培养基进行细胞因子ELISA检测。
6例CRS患者中有4例鼻窦灌洗液中检测到胃蛋白酶,3例对照组均未检测到。电子显微镜检查显示,经胃蛋白酶处理的HNEpC细胞出现线粒体损伤,而对照细胞未出现。MTT检测表明,与对照组相比,经胃蛋白酶处理的HNEpC细胞线粒体活性降低(P <.001)。胃蛋白酶增加了HNEpC细胞中IL-1A(P =.003)和IL-6(P =.04)的表达。
CRS患者鼻窦灌洗液中的胃蛋白酶与先前的研究结果一致。本研究揭示了胃蛋白酶在体外对鼻上皮细胞线粒体的损伤作用。体外胃蛋白酶处理HNEpC细胞后,先前与CRS相关的细胞因子水平升高。这些结果证明了胃蛋白酶可能加重CRS的机制。